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Abstract
Objective: Death certificates provide an invaluable source for cancer mortality
statistics; however, this value can only be realised if accurate, quantitative data
can be extracted from certificates — an aim hampered by both the volume and
variable nature of certificates written in natural language. This paper proposes
an automatic classification system for identifying cancer related causes of death
from death certificates.
Methods: Detailed features, including terms, n-grams and SNOMED CT con-
cepts were extracted from a collection of 447,336 death certificates. These fea-
tures were used to train Support Vector Machine classifiers (one classifier for
each cancer type). The classifiers were deployed in a cascaded architecture: the
first level identified the presence of cancer (i.e., binary cancer/no cancer) and
the second level identified the type of cancer (according to the ICD-10 classifi-
cation system). A held-out test set was used to evaluate the effectiveness of the
classifiers according to precision, recall and F-measure. In addition, detailed
feature analysis was performed to reveal the characteristics of a successful can-
cer classification model.
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Results: The system was highly effective at identifying cancer as the under-
lying cause of death (F-measure 0.94). The system was also effective at deter-
mining the type of cancer for common cancers (F-measure 0.7). Rare cancers,
for which there was little training data, were difficult to classify accurately (F-
measure 0.12). Factors influencing performance were the amount of training
data and certain ambiguous cancers (e.g., those in the stomach region). The
feature analysis revealed a combination of features were important for cancer
type classification, with SNOMED CT concept and oncology specific morphol-
ogy features proving the most valuable.
Conclusion: The system proposed in this study provides automatic identifi-
cation and characterisation of cancers from large collections of free-text death
certificates. This allows organisations such as Cancer Registries to monitor and
report on cancer mortality in a timely and accurate manner. In addition, the
methods and findings are generally applicable beyond cancer classification and
to other sources of medical text besides death certificates.
Keywords: Cancer classification, Death certificates, Machine Learning,
Natural Language Processing
1. Introduction
Cancer notification and reporting remains a critical activity for Cancer Reg-
istries who are charged with providing an accurate picture of the impact of
cancer, the effect of cancer treatments and to direct research efforts for cancer
control. A critical source of cancer information comes in the form of free-text5
death certificates, some of which will describe the type of cancer contributing
to death. German et al. [1] demonstrated the importance of analysing death
certificates to record cancer-related causes of death for population-based cancer
mortality statistics; such statistics from Cancer Registries are vital to measure
the effectiveness of healthcare systems and guide cancer control strategies [2].10
However, Cancer Registries receive an overwhelming number of death certifi-
2
cates (44,700 certificates annually for the Cancer Institute NSW1); only a por-
tion of these contain cancer (approx. 30% [3]). Manual identification of cancers
from this volume of certificates is resource intensive. An effective automated
method for cancer classification would allow for up-to-date mortality informa-15
tion used in the monitoring, planning and evaluating the management of cancers
that are of high public health importance.
In this paper, we propose a system for the automatic classification of cancers
from free-text death certificates. The systems has two main components: i)
a natural language processing (NLP) pipeline that extracts detailed features20
(e.g., terms, n-grams, SNOMED CT codes and ICD-O properties) from death
certificates; and ii) a set of machine learning classifiers that exploit these features
to determine the presence of cancers. The classifiers are deployed in a two-level,
cascaded architecture: the first level identified the presence of cancer (i.e., binary
cancer/no cancer) and the second level identifies the type of cancer (according25
to the ICD-10 classification system).
A detailed empirical evaluation on 10 years of semi-manually coded death
certificates shows that the proposed system is highly accurate at detecting men-
tions of cancers (0.942 F-measure on binary classification). The systems is also
effective at determining the type of common cancers (average F-measure of 0.730
for the top 20 cancer, which account for 85% of all cancer cases). For rarer can-
cers, where little data is available to train the classification model, the system
is less effective (F-measure of 0.12 on the 15% rarer cancer cases). Finally, a
detailed analysis reveals the characteristics of a successful cancer classification
model, including the effect of the amount of training data, ambiguity of the35
terms expressing the cancer, whether the cancer was actually the underlying
cause of death and, importantly, the discriminative power of different feature
types. The findings of this study helps guide the development of other text
classification tasks beyond cancer classification and could be applied to other
data sources besides death certificates.40
1Annual average for years 1999–2008, obtained using the dataset from this study.
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2. Task Description — Identifying Cancer from Death Certificates
The use case or task proposed in this study has two parts. Give a free-
text death certificate, the aims are to 1) determine if cancer was the cause
of death; and 2) if it was, determine the type of cancer (according to ICD-
10 classification system). Before detailing in the next section how this can45
be achieved with an automated classification system, this section provides an
understanding of the particular characteristics of death certificates and the data
collection methods used in this study; this helps to understand the design of the
automated classification system.
2.1. Death Certificate Format50
Death certificates are authored according to a specific procedure recom-
mended by the World Health Organisation [4] and therefore affects how any
automated classification is both developed and evaluated. Figure 1 provides a
sample death certificate. Section (I) contains the main causes of death with the
first entry, A), being the “Disease or condition directly leading to death”. The55
ordering of section (I) should be interpreted as A) “due to or as a consequence
of” B) “due to...” C), with the last entry, C), often listed as the underlying
cause of death. Section (II) contains “Other significant conditions contributing
to the death, but not related to the disease condition causing it”. For each
entry, a duration between onset of the condition and death is stated. For the60
use case of cancer classification proposed in this study, the sample certificate
presented here should firstly be classified as a cancer related death and secondly
classified as of type C16 (Malignant neoplasm of stomach).2
2.2. Collection of Death Certificates
The Cancer Institute of NSW supplied free-text, de-identified death certifi-65
cates for the years 1999-2008 (inclusive).3 The certificates were divided into
2Note that for this certificate the underlying cause of death is taken from Section (I-B),
not from the final entry in Section (I-C).
3The NSW Population & Health Services Research Ethics Committee granted ethics under
application HREC/11/CIPHS/60.
4
(I) A) HYPOXIC BRAIN INJURY, 5 MINUTES
B) GASTRIC CARCINOMA WITH GASTRECTOMY, 2 MONTHS
C) ATRIAL FIBRILLATION, 6 MONTHS
(II) HYPERCALCAEMIA, 5 YEARS
Figure 1: Sample death certificate. The certificates conforms to a format recommended by
the World Heath Organisation, where section (I) contains the causes directly leading to death
and (II) contains other contributing conditions.
Training set Testing set
Years 1999–2006 2007-2008
Num. certificates 355,165 92,171
% cancer 29.0% 29.9%
Table 1: Dataset of death certificates; separated into training and test sets based on the year
the death certificate was issued.
separate training and testing sets so that automatic methods could be devel-
oped using certificates from the training set and subsequently evaluated on
certificates from the unseen test set. The train/test split was based on the year
the certificate was issued, with details provided in Table 1. The split of training70
and testings sets by date was deliberately done because this reflects the realis-
tic setting in which the system would be used in a cancer registry. In such a
real-world setting, a classifier could only be trained on retrospective data from
previous years and then used to classify data from the current year; thus we
replicate this situation in our experimental methodology.75
2.3. Ground Truth
The Australian Bureau of Statistics is responsible for maintaining statistics
on causes of death in Australia. This is done by the semi-automatic assign-
ment of ICD-10 codes to death certificates [4]. These ICD-10 codes constitute
the ground truth against which the automated classification method is evalu-80
ated. For each death certificate, the single underlying cause of death is recorded
against that certificate (additional causes of death were not available for this
study). All ICD-10 codes were truncated at the three character level; for exam-
ple, the code C34.1 (Malignant neoplasm: Upper lobe, bronchus or lung) was
5
converted to simply C34 (Malignant neoplasm of bronchus and lung).85
Cancer cases were identified as those certificates assigned any ICD-10 code
from ICD-10 Chapter II (Neoplasms) [5], including in-situ and benign cancers
(i.e., all codes in the range“C00” to “D49”). For individual ICD-10 classification,
only “C” codes were considered as these were considered notifiable by the Cancer
Registry in which this study was conducted. (A list of these codes and their90
descriptions is provided in Appendix A.) The frequency distribution according
to the type of cancer is shown in Figure 2. The figure shows that a small subset
of cancer types make up the vast majority of cancer-caused deaths. In fact,
the top 20 most prevalent cancers constitute approximately 85% of all cancer
deaths. These top 20 cancers are therefore important to accurately classify with95
any automated method.
3. Feature Extraction Methods
The first component of the automated cancer classification system is a natu-
ral language processing pipeline that extracts from a death certificate an array
of different features that can be used to train a classification model. A number100
of different feature types are used; these fall into two different categories: i) ba-
sic term-based features taken directly from the text of the death certificate; and
ii) concept-based features, derived from the original terms, where concepts be-
long to standard medical terminologies (e.g., the SNOMED CT ontology). The
process of extracting concepts from free-text is performed by Medtex, a clinical105
natural language processing system [6, 7]. Table 2 describes the different types
of features extracted, belonging to these two categories. For each feature type,
the table columns provide i) a description the feature type; ii) a sample fragment
of a death certificate; iii) the resulting features that are consequently derived
from the fragment of the death certificate. The feature types listed here were110
chosen because they were shown to be successful in a previous study on binary
(cancer/nocancer) classification of death certificates [8].
Once all features are extracted, death certificates are transformed from orig-
6
Placenta (C58)Secondary lymph nodes (C77)
Kaposi sarcoma (C46)Other male genital organs (C63)
Trachea (C33)Other lymphoid, haematopoietic and related tissue (C96)
Other respiratory system and intrathoracic organs (C39)Leukaemias of specified cell type (C94)
Nasal cavity and middle ear (C30)Spinal cord, cranial nerves and central nervous system (C72)
Peripheral nerves and autonomic nervous system (C47)Other major salivary glands (C08)
Meninges (C70)Gum (C03)
Penis (C60)Thymus (C37)
Bone and articular cartilage of limbs (C40)Other female genital organs (C57)
Endocrine glands and related structures (C75)Base of tongue (C01)
Renal pelvis (C65)Monocytic leukaemia (C93)
Lip (C00)Testis (C62)
Piriform sinus (C12)Palate (C05)
Accessory sinuses (C31)Hypopharynx (C13)
Ureter (C66)Vagina (C52)
Follicular lymphoma (C82)Eye and adnexa (C69)
Other and unspecified urinary organs (C68)Heart, mediastinum and pleura (C38)
Malignant immunoproliferative diseases (C88)Floor of mouth (C04)
Adrenal gland (C74)Other parts of mouth (C06)
Tonsil (C09)Parotid gland (C07)
Vulva (C51)Anus and anal canal (C21)
Mature T/NK−cell lymphomas (C84)Hodgkin lymphoma (C81)
Oropharynx (C10)Nasopharynx (C11)
Other lip, oral cavity and pharynx (C14)Retroperitoneum and peritoneum (C48)
Bone and articular cartilage (C41)Secondary other and unspecified sites (C79)
Small intestine (C17)Thyroid gland (C73)
Uterus (C55)Other parts of biliary tract (C24)
Secondary respiratory and digestive organs (C78)Leukaemia of unspecified cell type (C95)
Ill−defined sites (C76)Parts of tongue (C02)
Gallbladder (C23)Non−follicular lymphoma (C83)
Connective and soft tissue (C49)Corpus uteri (C54)
Cervix uteri (C53)Larynx (C32)
Independent multiple sites (C97)Lymphoid leukaemia (C91)
Other skin (C44)Mesothelioma (C45)
Rectosigmoid junction (C19)Multiple myeloma and plasma cell neoplasms (C90)
Rectum (C20)Other digestive organs (C26)
Ovary (C56)Myeloid leukaemia (C92)
Kidney (C64)Bladder (C67)
Liver & intrahepatic bile ducts (C22)Brain (C71)
Oesophagus (C15)Stomach (C16)
Other non−Hodgkin lymphoma (C85)Melanoma of skin (C43)
Pancreas (C25)Unspecified site (C80)
Breast (C50)Colon (C18)
Prostate (C61)Bronchus and lung (C34)
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Figure 2: Prevalence of different cancers from ground truth for full set of death certificates
(1999–2008).
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inal terms to vectors of features (one vector per certificate); for example, each
word (TokenStem) or SNOMED CT concept represents a single feature dimen-115
sion in the vector, with features grouped into high level feature types (TokenStem
or SCTConceptId). The actual values in the vector are a binary indication if that
feature is present in the particular death certificate. Once each death certificate
is represented as a feature vector, this feature vector is used as the input to the
machine learning classifier.120
4. Classification Methods
The overall task description proposed in this study is to first identify if cancer
was a cause of death and if so determine the type of cancer. We translate this
into a machine learning strategy of 1) a single binary classifier that is trained
to assign a cancer/nocancer label to a death certificate; and 2) multiple ICD-10125
binary classifiers, one for each type of cancer, trained to assign the particular
ICD-10 label to a death certificate. The classifiers are deployed in a two-level,
cascaded architecture: a death certificate is first issued to the binary cancer/no
cancer classifier and if positive the certificate is issued to all the individual ICD-
10 classifiers. Thus the binary cancer/nocancer classifier can be referred to as130
the binary filter classifier.
For the implementation of the classifiers we use Support Vector Machines
(SVMs).4 SVMs were chosen as they were the best performing classification
model in a previous death certificate classification task [8]. The Weka toolkit
was used for the SVM implementation [10]. The parameters for all classifiers135
were set to the defaults described in Witten et al. [10].
In total, 86 SVMs were developed (85 for ICD-10 and 1 for cancer/nocancer).
The cancer/nocancer classifier was trained using the full training set; i.e., all the
death certificates in the training set (of which 29% were cancers and 71% were
4A Support Vector Machine (SVM) is a discriminative classifier formally defined by a
separating hyperplane. In other words, given labeled training data (supervised learning), the
algorithm outputs an optimal hyperplane which categorizes new examples.
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non-cancers). In contrast, the ICD-10 classifiers were trained using a balanced140
training set, constructed using the following method: for each ICD-10 code,
e.g., CXX, take all the positive CXX cases in the original training set (1999–
2006) and include them in a CXX training set with an equal number of non-
CXX cancer cases, randomly sampled from the original training set. This was
done to ensure that classifiers with small numbers of cases were trained with145
sufficient attention to positive cases and not skewed by overwhelming number
to negative cases [11]. In addition, the use of a balanced approach reduced the
computational cost of training, making a large scale evaluation feasible. For
comparison to the balanced method, two ICD-10 classifiers (C50 and C34) were
also trained using the full method. The performance of these (F-measure) was150
compariable with that of the classifiers trained using the balanced method.
On completion of training, all SVMs were used to classify each certificate in
the test set, with the cancer/nocancer classifier used as a filter to the ICD-10
classifiers (i.e., ICD-10 classification were only recorded if there was a preceding
positive cancer classification).155
5. Empirical Evaluation
5.1. Evaluation Measures
Two evaluation measures are considered: precision and recall. Precision (also
called positive predictive value) is the fraction of positively classified certificates
that are cancer5, while recall is the fraction of actual cancer certificates that160
are positively classified.6 For Cancer Registries, both precision and recall are
important: a high precision indicates that the system assigns the right ICD-10
code to a certificate mentioning cancer, while a high recall indicates the system
does not miss certificates that contain cancers (particularly important for rare
cancers). To provide a single, overall evaluation measure, precision and recall165
5Precision = True Positives / (True Positives + False Positives).
6Recall = True Positives / (True Positives + False Negatives).
10
Precision Recall F-measure
0.913 0.972 0.942
Table 3: Binary classification results — Evaluation metrics.
Classifier
- +
Ground - 61,278 2,622
truth + 789 27,482
Table 4: Binary classification results — Confusion matrix; + denotes cancer and - denotes
nocancer.
are combined into a third evaluation measure, F-measure.7
For analysis and interpretation of the ICD-10 classification results, results
were divided into two sets, constituting common and rare cancers. The set of
common cancers was derived by: i) ranking ICD-10 classes in descending order
of prevalence (according to the ground truth of the testset); and ii) selecting the170
top k cancers such that 85% of all cancer cases were covered. The set of rare
cancers was simply those ICD-10 classes not contained in the top k common
cancers; these constituted the remaining 15% of cancer cases.
5.2. Classification Results
The classification results for the binary (cancer / nocancer) classifier are175
shown in Table 3. In addition, a confusion matrix, which provides a breakdown
of true positives, false positives, true negatives and false negatives, is shown in
Table 4. Both precision and recall are high. Precision is reduced by a number
of false positives (2,622 in total) and recall reduced by a smaller number of false
negatives (789 in total).180
The individual ICD-10 classification results are shown in Figure 3 (divided
between common and rare cancers). Generally, recall is high but overall ef-
fectiveness (F-measure) is reduced by lower precision due to false positives.
Performance is better on the common cancers and worse on the rare cancers.
7F-measure = 2 * (precision * recall) / (precision + recall).
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(a) Common cancers, constituting 85% of cancer cases.
C7
3
C5
5
C5
3
C9
1
C0
2
C2
3
C5
4
C3
2
C5
1
C4
4
C8
4
C8
3
C1
4
C0
9
C0
7
C4
9
C9
5
C9
7
C0
6
C4
5
C7
6
C8
1
C0
4
C5
2
C1
1
C1
7
C4
8
C8
8
C1
0
C0
5
C2
4
C4
1
C6
2
C8
2
C0
1
C6
6
C7
4
C1
3
C4
6
C2
1
C9
3
C6
8
C3
8
C0
8
C6
9
C1
2
C3
1
C6
5
C0
0
C3
9
C5
7
C3
7
C4
0
C0
3
C7
0
C4
7
C7
5
C6
0
C3
0
C6
3
C7
8
C9
6
C3
3
C9
4
C7
2
0
10
0
20
0
30
0
40
0
50
0
60
0
N
um
be
r o
f c
as
es
l
l l l
l l l
l
l
l
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l0.0
0.2
0.4
0.6
0.8
1.0
Pe
rfo
rm
a
n
ce
l F−measure Precision Recall Number of cases
(b) Rare cancers, constituting 15% of cancer cases.
Figure 3: ICD-10 Classification results: precision, recall and F-measure. Cancers are ordered
in descending F-measure.
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5.3. Effect of Binary Cancer/NoCancer Filter185
The two-level classification method (cancer/nocancer, then ICD-10 classifi-
cation) was an intentional design decision to improve the effectiveness of the
ICD-10 classifier; the purpose being to reduce the number of false positives
provided by ICD-10 classification. To quantify the effect that the binary filter
had on performance, Figure 4 reports the results of the ICD-10 classifiers with190
and without the binary filter.8 The binary filter clearly led to a substantial
improvement in classification effectiveness, mainly by reducing false positives in
the ICD-10 classifiers (i.e., improvements in precision rather than recall).
6. Analysis and Discussion
6.1. Classifier Characteristics Impacting Performance195
The results showed that performance was superior on common cancers than
on rare cancers. One explanation for this is that the more training data, the bet-
ter the classifier performance. Figure 5 shows the number of training instances
vs. F-measure for each ICD-10 classifier. There was a correlation between train-
ing size and performance (Pearson’s correlation coefficient was 0.65). However,200
8For brevity, we only report results for common cancer, although the same trend applied
to rare cancers.
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Figure 5: F-measure compared with training set size; correlation 0.65.
this was not the case for all cancers; for example, cancers such as C80 and C25
had a large training set but low F-measure. This shows that some cancers were
harder to classify than others (e.g., C25 was Malignant neoplasm of pancreas
and cancers related to the stomach (spleen, pancreas, liver) were often hard
to differentiate). While training data was a determining factor, it was not the205
only factor. The next section investigates the different feature types which were
more discriminative.
6.2. Feature Type Analysis
To understand the value of each of the different feature types (previously
outlined in Table 2), we performed a feature analysis study for each of ICD-10210
classifiers. Training separate SVMs for each combination of feature type was not
feasible (5! feature type combinations × 85 ICD-10 classes = 10,200 SVMs).
Therefore an alternative Information Gain analysis, often applied in machine
learning method [10, Sec. 7.1], was applied. Using this method, the worth of
a feature was determined by measuring the Information Gain with respect to215
the predicting class; it can be estimated as IG(C,F ) = H(C)−H(C|F ), where
C is the class (ICD-10 in this case), F is the particular feature of interest and
H is the information entropy. The Information Gain of each feature for each
ICD-10 class was calculated and features were then ranked by Information Gain,
i.e., in descending order of discriminative power. Finally, features were mapped220
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Rank Feature Feature Type Info. Gain
1 colorect TokenStem 0.423
2 264267007 (Colorectal) SCTConceptId 0.422
3 77879006 (Metastatic to) SCTConceptId 0.096
4 5.Unspecified carcinomas ICDOMorphBerg 0.089
5 79282002 (Carcinoma, metastatic) SCTConceptId 0.081
6 metastat TokenStem 0.069
7 17.Unspecified type of cancer ICDOMorphBerg 0.066
8 metastat cancer colorect TokenStemNGram 0.057
9 14799000 (Neoplasm, metastatic) SCTConceptId 0.056
10 cancer TokenStem 0.055
... ... ... ...
Table 5: Top 10 features ranked using Information Gain for C19 (Malignant neoplasm of
rectosigmoid junction) classifier. The most discriminative feature for determining if the cause
of death was C19 was the presence of the TokenStem colorect, then the presence of the
SNOMED CT concept 264267007.
to their respective feature types (e.g., TokenStem, SCTConcept, etc.) in order
to determine which feature type was most discriminative. An example of the
top 10 features, ranked by Information Gain, for the C19 classifier is shown
in Table 5. Using the method described above, both the rank and the score of
different feature types were analysed to determine how effective different feature225
types were in discriminating each ICD-10 classification.9
The different feature types according to Information Gain score are shown in
Figure 6(a). We observe that there were a number of outliers with a high score
from the SCTConceptId feature type. This means that in certain cases (e.g.,
C16 or C56) the SNOMED CT concept id was a key discriminative feature230
that indicated this type of cancer; in some cases, this occured together with
a high Information Gain for the TokenStem (e.g., C61, C90), while in others
it was the SNOMED CT concept alone that was discriminative (e.g., C25).
While TokenStem was discriminative in a number of cases (e.g., C18, C34),
TokenStemNGram did not prove a strong discriminative feature. Finally, the two235
cancer specific features, ICDOMorphBerg and ICDOSiteGroup sometimes proved
9Note, we are concerned with the rank of the feature type not the feature itself; i.e., the
“Feature Type” column in Table 5.
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(a) Boxplot showing feature type vs. Information Gain score.
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(b) Feature type vs. rank position.
Figure 6: Feature type analysis showing the discriminative power of each feature type, ordered
by negative rank (-Rank). 16
valuable (e.g., C56, C71, C90).
The different feature types according to Information Gain negative rank are
shown in Figure 6(b).10 Here a different story emerges: features of type ICDO-
MorphBerg and ICDOSiteGroup were consistently the most discriminative (i.e.,240
were the top-ranked features). The other three feature types, SCTConceptId,
TokenStem and TokenStemNGram, were consistently found lower in the rank-
ing of discriminative features, with SCTConceptId slightly above TokenStem and
TokenStem slightly above TokenStemNGram.
The difference between the score results of Figure 6(a) and the negative rank245
results of Figure 6(b) revealed that although SCTConceptId and TokenStem had
some high Information Gain scores at the top of ranking, they also had many
low scores at the bottom of the ranking. This means they were not consistently
reliable features. In addition, the ICDOMorphBerg and ICDOSiteGroup were far
less common (i.e., they only occur for some death certificates) but that when250
they did occur they were important indicators for the correct cancer-related
cause of death for that certificate.
In summary, no single feature type was discriminative across the board for
ICD-10 classification. The cancer specific ICDOMorphBerg and ICDOSiteGroup
were particularly discriminative but cannot be relied upon as they did not occur255
in every certificate. The SCTConceptId feature generally proved more valuable
than TokenStem; TokenStemNGram added little.
7. Limitations and Future Work
The ground truth ICD-10 code for a death certificate (described in Sec-
tion 2.3) was the single underlying cause of death for that certificate; ICD-10260
codes were not available for additional causes of deaths listed in the certificate.
For some certificates, cancer may have been recorded in the text of the death
certificate but may not have been the underlying cause of death and there-
10Negative rank position was used so that the most discriminative features (i.e., those with
low rank numbers) appear at the top of the plot.
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(I) A) MYOCARDIAL INFARCTION, MINUTES
B) DIABETES, 6 YEARS
(II) BREAST CANCER, 6 YEARS
Figure 7: Death certificate listing breast cancer as a contributing cause of death but with the
primary cause of death being the diabetes listed in Section (I)(B).
fore the ground truth would not record this certificate as being cancer related.
For example, consider the death certificate presented in Figure 7. In this case,265
based on the presence of breast cancer in the text, the machine learning classi-
fiers would have marked the certificate as being cancer, thus leading to a false
positive classification. A consequence of this would be that the evaluation un-
derestimated the effectiveness of the classifiers (certainly, false positives were
the main source of errors). Two avenues of future work can be pursued to ad-270
dress this issue. Firstly, alternative ground truth that records both underlying
and additional causes of death may be sort out, however such information is
currently not available and may be laborious to develop from scratch. Secondly,
and alternative to new ground truth, the feature extraction and classification
methods in this study can be extended to take into account the death certifi-275
cate structure (i.e., Section (I) or (II)), using this as an additional feature in the
classification task. (Note that the underlying cause is not always simply the last
entry in Section (I); instead, there are a series complex rules that are employed
when determining the underlying cause of death [12].)
The evaluation was done independently for each ICD-10 classification. In280
reality, the system would run in parallel with each classifier assigning a positive
or negative label to a death certificate. In this case, it is possible for a single
certificate to be assigned multiple ICD-10 codes. If the ground truth contains a
single underlying cause of death then a method is required to fuse the multiple
ICD-10 classifications results into a final ICD-10 code. One fusion method is to285
use the SVM distance from the hyperplane to assign a probability of correctness
and select the classifier with highest likelihood. Other fusion methods may bias
the choice based on the type of cancer (e.g., to ensure rare cancers are identified
18
by the system). The investigation of fusion methods is currently being pursued
as future work.290
The empirical results showed poor performance on very rare cancers where
very little training data was available. For these cases a supervised machine
learning approach may not be desirable. Symbolic, rule-based approaches have
been successful in other cancer identification tasks [13] and may be applied here.
Using the fusion method approach described in the previous paragraph, a hybrid295
approach, rules in conjunction with the SVMs, could be used; the fusion method
could use evidence from both the rules and the SVMs in determining the final
classification for a certificate.
Finally, the feature analysis based on Information Gain revealed key discrim-
inative features. Many features had an Information Gain score of zero (i.e., they300
provided no indication as to what classification label to apply to a certificate).
Future work will investigate a feature reduction method based on Information
Gain to considerably reduce the feature space and produce more efficient SVMs
(both in terms of training time and memory usage: time and space). This is
an important requirement for Cancer Registries who have to efficiently process305
large volume of death certificates.
7.1. Related Work
Cancer registries are increasingly turning to automated methods to extract
cancer related statistics from increasing volumes of the cancer related data they
receive. For example, the Danish Cancer Registry introduced electronic report-310
ing and integration with the patient administrative system [14]; in Australia,
cancer notifications and synoptic reporting are performed automatically from
pathology and cytology reports [6]. These case studies show there is both a need
and viable use case for automated classification of cancers from cancer registry
data.315
There have been a number of text mining applications specifically focusing
on extracting cancer related information; Spasic et al. [15] provides a compre-
hensive review of these. The review highlighted a strong bias towards symbolic
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techniques, i.e., the use of pattern matching and dictionary lookup for cancer-
related entity extraction. A number of symbolic approaches make us of some320
natural language processing and pattern matching aided by some medical do-
main knowledge resource, either the UMLS Metathesaurus [16, 17] or some other
resource [18]. The survey of these approaches identified some limiting factors for
symbolic techniques: i) the effort required to develop manual rules, which have
to be defined on a case-by-case basis for each cancer type; and ii) brittleness325
of symbolic approach to the idiosyncrasies of the clinical sublanguage such as
non-standard abbreviations as well as a high degree of spelling and grammat-
ical errors. The authors conclusion is that a shift from rule-based methods to
machine learning is required.
Some machine learning methods have been applied to text classification for330
cancer. Butt et al. [8] developed a binary (i.e., cancer or no-cancer) classifier for
free-text death certificates. They investigated a number of different statistical
classifiers. These classifiers were evaluated on a small 5,000 report subset of
data from Cancer Institute New South Wales: this data is similar to that used
in the present article. They found that Support Vector Machines performed335
best in determining whether cancer was the underlying cause of death: this
provided initial evidence for using Support Vector Machine classifiers in our
work. There are three important distinctions between this previous study and
the work described in this paper: i) we developed a set of ICD-10 classifiers
that determined the type of cancer, whereas Butt et al. simply developed a340
binary classifier for the presence of cancer (not the type); ii) we conducted an
extensive empirical investigation on a large dataset to determine the robustness
and general applicability of our methods; and iii) we analysed the factors and
features that affected the performance of automated cancer classification.
8. Conclusion345
This study provides a system for automatically identifying and character-
ising cancers from large collections of free-text death certificates. This allows
20
Cancer Registries to monitor and report on cancer mortality in a timely and ac-
curate manner. The proposed system has two components: a natural language
processing pipeline that extracts features (both term and concept-based) from350
death certificates; and a series of supervised Support Vector Machines, that
utilise the extracted features for classification. The system is very effective in
determining if cancer was a cause of death (F-measure of 0.942 on binary can-
cer/nocancer) and is also effective at determining the type of common cancers
(average F-measure of 0.7), while rare cancers are more challenging (F-measure355
of 0.12). The two-level architecture of first identifying if cancer is present and
then determining the type of cancer (according to ICD-10) is an important
method to improve the accuracy of the ICD-10 classification.
Although the amount of training data was a factor influencing performance
(performance was worse for rarer cancers), it was not the only influencing factor360
and that certain cancers (e.g., those in the stomach region) were harder to
classify than others. Detailed feature analysis via Information Gain revealed
that no single feature type is most discriminative in determining the type of
cancer, although the use of SNOMED CT concepts and ICD-O morphology and
site features proved most valuable. For rarer cancers, a symbolic rule-based365
approach may be more suited; this method can be included with SVMs in a
hybrid method that fuses results from different SVMs and rules to determine a
final ICD-10 classification. This is an active area of future work.
The methods and findings of this study are generally applicable; they can
be transferred to other ICD-10 classification task beyond cancer classification370
and to other source of medical free-text besides death certificates.
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Appendix A. ICD-10 Code Descriptions
ICD-10 codes covering cancer considered in this study.440
C00 Malignant neoplasm of lip
C01 Malignant neoplasm of base of tongue
C02 Malignant neoplasm of other and unspecified parts of tongue
C03 Malignant neoplasm of gum
C04 Malignant neoplasm of floor of mouth
C05 Malignant neoplasm of palate
C06 Malignant neoplasm of other and unspecified parts of mouth
C07 Malignant neoplasm of parotid gland
C08 Malignant neoplasm of other and unspecified major salivary glands
C09 Malignant neoplasm of tonsil
C10 Malignant neoplasm of oropharynx
C11 Malignant neoplasm of nasopharynx
C12 Malignant neoplasm of piriform sinus
C13 Malignant neoplasm of hypopharynx
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity
and pharynx
C15 Malignant neoplasm of oesophagus
C16 Malignant neoplasm of stomach
C17 Malignant neoplasm of small intestine
C18 Malignant neoplasm of colon
C19 Malignant neoplasm of rectosigmoid junction
C20 Malignant neoplasm of rectum
C21 Malignant neoplasm of anus and anal canal
C22 Malignant neoplasm of liver and intrahepatic bile ducts
C23 Malignant neoplasm of gallbladder
C24 Malignant neoplasm of other and unspecified parts of biliary tract
C25 Malignant neoplasm of pancreas
C26 Malignant neoplasm of other and ill-defined digestive organs
C30 Malignant neoplasm of nasal cavity and middle ear
C31 Malignant neoplasm of accessory sinuses
C32 Malignant neoplasm of larynx
C33 Malignant neoplasm of trachea
C34 Malignant neoplasm of bronchus and lung
C37 Malignant neoplasm of thymus
C38 Malignant neoplasm of heart, mediastinum and pleura
C39 Malignant neoplasm of other and ill-defined sites in the respiratory
system and intrathoracic organs
C40 Malignant neoplasm of bone and articular cartilage of limbs
C41 Malignant neoplasm of bone and articular cartilage of other and un-
specified sites
C43 Malignant melanoma of skin
C44 Other malignant neoplasms of skin
C45 Mesothelioma
C46 Kaposi sarcoma
25
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
C48 Malignant neoplasm of retroperitoneum and peritoneum
C49 Malignant neoplasm of other connective and soft tissue
C50 Malignant neoplasm of breast
C51 Malignant neoplasm of vulva
C52 Malignant neoplasm of vagina
C53 Malignant neoplasm of cervix uteri
C54 Malignant neoplasm of corpus uteri
C55 Malignant neoplasm of uterus, part unspecified
C56 Malignant neoplasm of ovary
C57 Malignant neoplasm of other and unspecified female genital organs
C58 Malignant neoplasm of placenta
C60 Malignant neoplasm of penis
C61 Malignant neoplasm of prostate
C62 Malignant neoplasm of testis
C63 Malignant neoplasm of other and unspecified male genital organs
C64 Malignant neoplasm of kidney, except renal pelvis
C65 Malignant neoplasm of renal pelvis
C66 Malignant neoplasm of ureter
C67 Malignant neoplasm of bladder
C68 Malignant neoplasm of other and unspecified urinary organs
C69 Malignant neoplasm of eye and adnexa
C70 Malignant neoplasm of meninges
C71 Malignant neoplasm of brain
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of
central nervous system
C73 Malignant neoplasm of thyroid gland
C74 Malignant neoplasm of adrenal gland
C75 Malignant neoplasm of other endocrine glands and related structures
C76 Malignant neoplasm of other and ill-defined sites
C77 Secondary and unspecified malignant neoplasm of lymph nodes
C78 Secondary malignant neoplasm of respiratory and digestive organs
C79 Secondary malignant neoplasm of other and unspecified sites
C80 Malignant neoplasm, without specification of site
C81 Hodgkin lymphoma
C82 Follicular lymphoma
C83 Non-follicular lymphoma
C84 Mature T/NK-cell lymphomas
C85 Other and unspecified types of non-Hodgkin lymphoma
C88 Malignant immunoproliferative diseases
C90 Multiple myeloma and malignant plasma cell neoplasms
C91 Lymphoid leukaemia
C92 Myeloid leukaemia
C93 Monocytic leukaemia
C94 Other leukaemias of specified cell type
C95 Leukaemia of unspecified cell type
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoi-
etic and related tissue
C97 Malignant neoplasms of independent (primary) multiple sites
26
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